Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfSPZ Vaccine in Equatoguinean Adults
NCT02418962Phase 1Completed
- Sponsor
- Sanaria Inc.
- Start
- Mar 2015
- Primary completion
- Sep 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Sanaria PfSPZ Vaccine in malaria (3 arms), sponsored by Sanaria Inc. Primary endpoints: Number of adverse events as a measure of safety and tolerability, Number of serious adverse events and 1 more. Started Mar 2015; status: completed.
02
Drugs
Sanaria PfSPZ Vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02418962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02418962.